Risk of Epithelial Ovarian Cancer Recurrence in Patients With Rising Serum CA-125 Levels Within the Normal Range

This publication has 17 references indexed in Scilit:

• Clinical implications of a rising serum CA-125 within the normal range in patients with epithelial ovarian cancer: a preliminary investigation☆
  Gynecologic Oncology, 2003
• Use of CA-125 to Define Progression of Ovarian Cancer in Patients With Persistently Elevated Levels
  Journal of Clinical Oncology, 2001
• Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers
  Journal of the American Statistical Association, 2001
• Biological variation and analytical imprecision of CA 125 in patients with ovarian cancer
  Scandinavian Journal of Clinical and Laboratory Investigation, 2000
• Risk of diagnosis of ovarian cancer after raised serum CA 125 concentration: a prospective cohort study
  BMJ, 1996
• Evaluation of a risk of malignancy index based on serum CA125, ultrasound findings and menopausal status in the pre‐operative diagnosis of pelvic masses
  BJOG: An International Journal of Obstetrics and Gynaecology, 1996
• Defining progression of ovarian carcinoma during follow-up according to CA 125: A North Thames Ovary Group study
  Annals of Oncology, 1996
• A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer
  BJOG: An International Journal of Obstetrics and Gynaecology, 1990
• Tribute to Patrick Steptoe: beginnings of laparoscopy
  Human Reproduction, 1989
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983